Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys

NCT00001984 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Graft Rejection
Kidney Disease

Interventions

DRUG: Alemtuzumab and DSG

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)